Your leading voice in digital health news
Twitter X Logo

Healthscope exits GP market, boosts tech investment in pathology

25 August 2017
By Kate McDonald

Private hospital and pathology laboratory operator Healthscope has reported a decline in net profit of almost 40 per cent for the 2017 financial year, mainly due to a write-down from the sale of its 43-strong medical centre portfolio, but the company says it will continue to invest in infrastructure and technology.

The ASX-listed multinational's new CEO, former Telstra executive Gordon Ballantyne, highlighted the New Zealand pathology division as a bright spot with increased investment in technology leading to efficiency gains, but said the hospital division was suffering from soft market conditions.

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Copyright © 2024 Pulse IT Communications Pty Ltd. No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher. If your organisation is featured in a Pulse+IT article you can purchase the permission to reproduce the article here.
Website Design by Get Leads AU.

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down